Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Bicuspid Aortic Valve clinical trials

3 of 5 indexed Bicuspid Aortic Valve trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Bicuspid Aortic Valve: 5 US clinical trials tracked, 3 recruiting.

Bicuspid Aortic Valve is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Cedars-Sinai Medical Center, running 2 of these trials.

Enrollment posture brief

Registry condition bicuspid-aortic-valve

OPEN 3 | RECR 60% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Bicuspid Aortic Valve (this)60%
Open-enrollment share among volume-matched conditions near Bicuspid Aortic Valve

Bicuspid Aortic Valve lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Bicuspid Aortic Valve on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Bicuspid Aortic Valve is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Bicuspid Aortic Valve research.

    Cedars-Sinai Medical Center accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical Bicuspid Aortic Valve enrolment sits around 2,000 participants.

    Median target enrolment is 2,000 among the 5 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.

  4. Bicuspid Aortic Valve research leans observational.

    2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Bicuspid Aortic Valve records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Medtronic TAVR Systems Device
1 trials
surgical aortic valve replacement (SAVR) Procedure
1 trials
transcatheter aortic valve replacement (TAVR) Procedure
1 trials
Transcatheter aortic valve replacement Device
1 trials

US sites by state

Facility locations filed on Bicuspid Aortic Valve trials. A trial with sites in several states counts in each.

California 3 trials
Michigan 2 trials
Massachusetts 2 trials
Oregon 1 trials
Ohio 1 trials
New York 1 trials
Minnesota 1 trials
Iowa 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Bicuspid Aortic Valve page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bicuspid Aortic Valve condition card totals 5 registered trials; most-linked intervention Medtronic TAVR Systems; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.